FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010717076> ?p ?o ?g. }

• W2010717076 endingPage "975" @default.
• W2010717076 startingPage "968" @default.
• W2010717076 abstract "Objective To investigate the aqueous levels of angiopoietin-like 4 (ANGPTL4), semaphorin 3E (Sema3E), and vascular endothelial growth factor (VEGF) in patients with diabetic retinopathy and to ascertain their association with diabetic retinopathy phenotypes. Design Prospective, nonrandomized, comparative case series. Participants Of all 104 consecutive patients (104 eyes) who had intravitreal anti-VEGF injections from April 2012 through April 2013 for diabetic macular edema (DME), 51 had severe nonproliferative diabetic retinopathy (NPDR) and 53 had proliferative diabetic retinopathy (PDR). The controls were 54 consecutive nondiabetic patients who had undergone cataract surgery (54 eyes) during the same period. Methods The ANGPTL4, Sema3E, and VEGF levels in aqueous humor samples obtained before intravitreal injections were measured by enzyme-linked immunosorbent assay. Capillary nonperfusion area (NPA) was calculated from encircled angiography using the 7 standard field images described in the Early Treatment Diabetic Retinopathy Study protocol. Total macular volume (TMV) was measured by spectral-domain optical coherence tomography. Main Outcome Measures Aqueous ANGPTL4, Sema3E, and VEGF levels in severe NPDR, PDR, and control groups and their correlations with each other, NPA, and TMV. Results The severe NPDR and PDR groups had higher aqueous levels of ANGPTL4 and VEGF than the control group (all P < 0.001). The PDR group had higher ANGPTL4 and VEGF levels than the severe NPDR group (both P < 0.001). The aqueous ANGPTL4 levels of all diabetic retinopathy patients correlated positively with NPA (r = 0.820, P = 0.003) and TMV (r = 0.824, P < 0.001). The control group had higher aqueous Sema3E levels than the NPDR and PDR groups (both P < 0.001). Aqueous Sema3E levels correlated negatively with VEGF levels in all subjects (r = −0.57, P = 0.025). Conclusions The ANGPTL4 may be a candidate target in DME treatment and a biomarker of ischemic-induced retinopathy, including diabetic retinopathy. To investigate the aqueous levels of angiopoietin-like 4 (ANGPTL4), semaphorin 3E (Sema3E), and vascular endothelial growth factor (VEGF) in patients with diabetic retinopathy and to ascertain their association with diabetic retinopathy phenotypes. Prospective, nonrandomized, comparative case series. Of all 104 consecutive patients (104 eyes) who had intravitreal anti-VEGF injections from April 2012 through April 2013 for diabetic macular edema (DME), 51 had severe nonproliferative diabetic retinopathy (NPDR) and 53 had proliferative diabetic retinopathy (PDR). The controls were 54 consecutive nondiabetic patients who had undergone cataract surgery (54 eyes) during the same period. The ANGPTL4, Sema3E, and VEGF levels in aqueous humor samples obtained before intravitreal injections were measured by enzyme-linked immunosorbent assay. Capillary nonperfusion area (NPA) was calculated from encircled angiography using the 7 standard field images described in the Early Treatment Diabetic Retinopathy Study protocol. Total macular volume (TMV) was measured by spectral-domain optical coherence tomography. Aqueous ANGPTL4, Sema3E, and VEGF levels in severe NPDR, PDR, and control groups and their correlations with each other, NPA, and TMV. The severe NPDR and PDR groups had higher aqueous levels of ANGPTL4 and VEGF than the control group (all P < 0.001). The PDR group had higher ANGPTL4 and VEGF levels than the severe NPDR group (both P < 0.001). The aqueous ANGPTL4 levels of all diabetic retinopathy patients correlated positively with NPA (r = 0.820, P = 0.003) and TMV (r = 0.824, P < 0.001). The control group had higher aqueous Sema3E levels than the NPDR and PDR groups (both P < 0.001). Aqueous Sema3E levels correlated negatively with VEGF levels in all subjects (r = −0.57, P = 0.025). The ANGPTL4 may be a candidate target in DME treatment and a biomarker of ischemic-induced retinopathy, including diabetic retinopathy." @default.
• W2010717076 created "2016-06-24" @default.
• W2010717076 creator A5038661112 @default.
• W2010717076 creator A5040191402 @default.
• W2010717076 creator A5045449915 @default.
• W2010717076 creator A5059923259 @default.
• W2010717076 date "2015-05-01" @default.
• W2010717076 modified "2023-10-14" @default.
• W2010717076 title "Aqueous Levels of Angiopoietin-like 4 and Semaphorin 3E Correlate with Nonperfusion Area and Macular Volume in Diabetic Retinopathy" @default.
• W2010717076 cites W1971826305 @default.
• W2010717076 cites W1972499026 @default.
• W2010717076 cites W1975726973 @default.
• W2010717076 cites W1985635605 @default.
• W2010717076 cites W1992159395 @default.
• W2010717076 cites W1992553297 @default.
• W2010717076 cites W1993419164 @default.
• W2010717076 cites W2009758003 @default.
• W2010717076 cites W2014148719 @default.
• W2010717076 cites W2018643656 @default.
• W2010717076 cites W2022084143 @default.
• W2010717076 cites W2024008844 @default.
• W2010717076 cites W2024046691 @default.
• W2010717076 cites W2027092108 @default.
• W2010717076 cites W2042789158 @default.
• W2010717076 cites W2043936005 @default.
• W2010717076 cites W2057253189 @default.
• W2010717076 cites W2057294991 @default.
• W2010717076 cites W2065539232 @default.
• W2010717076 cites W2069805049 @default.
• W2010717076 cites W2073676627 @default.
• W2010717076 cites W2085933963 @default.
• W2010717076 cites W2088059932 @default.
• W2010717076 cites W2107893047 @default.
• W2010717076 cites W2119584041 @default.
• W2010717076 cites W2126047917 @default.
• W2010717076 cites W2127013658 @default.
• W2010717076 cites W2129600117 @default.
• W2010717076 cites W2131160537 @default.
• W2010717076 cites W2140241614 @default.
• W2010717076 cites W2170736430 @default.
• W2010717076 cites W2315378299 @default.
• W2010717076 cites W2324588265 @default.
• W2010717076 cites W3114506327 @default.
• W2010717076 cites W4214688168 @default.
• W2010717076 cites W4244248663 @default.
• W2010717076 doi "https://doi.org/10.1016/j.ophtha.2015.01.007" @default.
• W2010717076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25687026" @default.
• W2010717076 hasPublicationYear "2015" @default.
• W2010717076 type Work @default.
• W2010717076 sameAs 2010717076 @default.
• W2010717076 citedByCount "39" @default.
• W2010717076 countsByYear W20107170762015 @default.
• W2010717076 countsByYear W20107170762016 @default.
• W2010717076 countsByYear W20107170762017 @default.
• W2010717076 countsByYear W20107170762018 @default.
• W2010717076 countsByYear W20107170762019 @default.
• W2010717076 countsByYear W20107170762020 @default.
• W2010717076 countsByYear W20107170762021 @default.
• W2010717076 countsByYear W20107170762022 @default.
• W2010717076 countsByYear W20107170762023 @default.
• W2010717076 crossrefType "journal-article" @default.
• W2010717076 hasAuthorship W2010717076A5038661112 @default.
• W2010717076 hasAuthorship W2010717076A5040191402 @default.
• W2010717076 hasAuthorship W2010717076A5045449915 @default.
• W2010717076 hasAuthorship W2010717076A5059923259 @default.
• W2010717076 hasConcept C118487528 @default.
• W2010717076 hasConcept C126322002 @default.
• W2010717076 hasConcept C134018914 @default.
• W2010717076 hasConcept C141071460 @default.
• W2010717076 hasConcept C167734588 @default.
• W2010717076 hasConcept C2777025900 @default.
• W2010717076 hasConcept C2778313320 @default.
• W2010717076 hasConcept C2779094623 @default.
• W2010717076 hasConcept C2779829184 @default.
• W2010717076 hasConcept C2780347916 @default.
• W2010717076 hasConcept C2780827179 @default.
• W2010717076 hasConcept C555293320 @default.
• W2010717076 hasConcept C71924100 @default.
• W2010717076 hasConceptScore W2010717076C118487528 @default.
• W2010717076 hasConceptScore W2010717076C126322002 @default.
• W2010717076 hasConceptScore W2010717076C134018914 @default.
• W2010717076 hasConceptScore W2010717076C141071460 @default.
• W2010717076 hasConceptScore W2010717076C167734588 @default.
• W2010717076 hasConceptScore W2010717076C2777025900 @default.
• W2010717076 hasConceptScore W2010717076C2778313320 @default.
• W2010717076 hasConceptScore W2010717076C2779094623 @default.
• W2010717076 hasConceptScore W2010717076C2779829184 @default.
• W2010717076 hasConceptScore W2010717076C2780347916 @default.
• W2010717076 hasConceptScore W2010717076C2780827179 @default.
• W2010717076 hasConceptScore W2010717076C555293320 @default.
• W2010717076 hasConceptScore W2010717076C71924100 @default.
• W2010717076 hasIssue "5" @default.
• W2010717076 hasLocation W20107170761 @default.
• W2010717076 hasLocation W20107170762 @default.
• W2010717076 hasOpenAccess W2010717076 @default.
• W2010717076 hasPrimaryLocation W20107170761 @default.
• W2010717076 hasRelatedWork W139291731 @default.
• W2010717076 hasRelatedWork W1803971831 @default.

• next